| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K33199242 |
| PharmacoGx | BRD-K33199242 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | G3BP1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | TARBP2 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | SEC22A | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | NDUFB4 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | DAPP1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | SET | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | TATDN3 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | KLK10 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | C16orf87 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | PUDP | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
